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ABSTRACT
Objective: The prevalence of coeliac disease (CD) in
Vietnam is unknown. To fill this void, we assessed the
prevalence of serological markers of CD autoimmunity
in a population of children in Hanoi.
Setting: The outpatient blood drawing laboratory of
the largest paediatric hospital in North Vietnam was
used for the study, which was part of an international
project of collaboration between Italy and Vietnam.
Participants: Children having blood drawn for any
reason were included. Exclusion criteria were age
younger than 2 years, acquired or congenital immune
deficiency and inadequate sample. A total of 1961
children (96%) were enrolled (838 females, 1123
males, median age 5.3 years).
Outcomes: Primary outcome was the prevalence of
positive autoimmunity to both IgA antitransglutaminase
antibodies (anti-tTG) assessed with an ELISA test and
antiendomysial antibodies (EMA). Secondary outcome
was the prevalence of CD predisposing human
leucocyte antigens (HLA) (HLA DQ2/8) in the positive
children and in a random group of samples negative
for IgA anti-tTG.
Results: The IgA anti-tTG test was positive in 21/1961
(1%; 95% CI 0.61% to 1.53%); however, EMA
antibodies were negative in all. HLA DQ2/8 was present
in 7/21 (33%; 95% CI 14.5% to 56.9%) of the
anti-tTG-positive children and in 72/275 (26%; 95% CI
21% to 32%) of those who were negative.
Conclusions: Coeliac autoimmunity is rare in
Vietnam, although prevalence of HLA DQ2/8 is similar
to that of other countries. We hypothesise that the
scarce exposure to gluten could be responsible for
these findings.
INTRODUCTION
Coeliac disease (CD) is a chronic
small-intestinal immune-mediated enterop-
athy precipitated by exposure to dietary
gluten in genetically predisposed individuals
bearing the second class human leucocyte
antigen (HLA) DQ2/DQ8 haplotypes.1 CD is
characterised by the presence of a variable
combination of clinical manifestations
including intestinal and extraintestinal symp-
toms such as diarrhoea, abdominal pain,
failure to thrive and anaemia. CD-speciﬁc
antibodies comprise antitransglutaminase
antibodies (anti-tTG), antiendomysial anti-
bodies (EMA) and antibodies against deami-
dated forms of gliadin peptides.2 The
sensitivity of anti-tTG and EMA is about 93%,
whereas speciﬁcity has been reported to be
97% for anti-tTG and 99% for EMA.
The prevalence of CD reported in Europe
and the USA averages 1% in children and
adults.3–5 A few studies have been performed
on symptomatic individuals in China and
India,6 but, with the exception of a screening
in Malaysian adults,7 the prevalence of CD in
the Asia-Paciﬁc region and, more speciﬁcally
in Vietnam, is still unknown. The World
Gastroenterology Organization and the Asian
Paciﬁc Association of Gastroenterology rec-
ommend establishing the prevalence of CD
across that region in order to increase
Strengths and limitations of this study
▪ This is the first research on coeliac disease
autoimmunity in Vietnam.
▪ HLA typing for DQ2 and DQ8 of the antitransglu-
taminase antibodies (anti-tTG)-positive children
and of a proportion of those who were negative
was carried out.
▪ A detailed questionnaire was used to collect
quantitative information about gluten consump-
tion to the best possible accuracy.
▪ The target population was composed of children
presenting to a hospital laboratory and therefore
by definition not completely healthy.
▪ A small-intestinal biopsy could not possibly be
performed and therefore we do not know if histo-
logical lesions were present in the few patients at
risk.
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awareness among physicians and patients.8 When
untreated, the disease can cause permanent growth
failure and poor bone development, and, according to
some studies, it can facilitate the development of auto-
immune disorders such as diabetes and thyroiditis, infer-
tility and even cancer.9 10 A twofold to threefold excess
in all-cause mortality among patients with untreated CD,
compared with the general population, has been
reported.11 12
While wheat is the staple cereal of most Caucasian
populations, the diet of many populations in Asia and
South-East Asia is based on rice.9 13 Wheat-based pro-
ducts, however, are becoming more common with
urbanisation and rising incomes in areas of Asia that
were once considered traditional rice-eating regions.
Changes in infant feeding patterns in Asian countries
might increase the prevalence of CD. We hypothesised
that eating mainly rice would protect one from develop-
ing coeliac autoimmunity.
In order to establish the prevalence of CD in the
Vietnamese paediatric population, we tested a large
number of children, using the serum anti-tTG as a
screening test. The children who tested positive for
anti-tTG were evaluated with the EMA test and for the
CD-related HLA. A randomly selected group of children
who had tested negative for anti-tTG and EMA were
typed for CD-related HLA.
MATERIALS AND METHODS
Study design
The study was designed by the University of Ferrara, Italy,
in collaboration with the National Hospital of Paediatrics
(NHP) in Hanoi, Vietnam, which are partners in an inter-
national project of the University of Ferrara. In addition,
the Institute for Clinical Research of the University of
Trieste, Italy, participated in the research project and per-
formed all the laboratory tests. The sample size was calcu-
lated on an estimation of 0.75% prevalence of CD.14
Considering a 99% CI and a precision of 0.5%, the esti-
mated sample size was 1976.15 We added 5% to the
sample size to compensate for any attrition.
The NHP is the second largest paediatric hospital in
Southeast Asia and the large daily inﬂux of children
allowed us to enrol the necessary number in a short
period of time. The children, aged 2–18 years, who pre-
sented to the laboratory of the NHP to have blood
drawn for any reason between February 2 and 14, 2015,
were included in the study. Exclusion criteria were: age
younger than 2 years, a diagnosis of malignancy and
chemotherapy or treatment with immunosuppressants,
including corticosteroids. In fact, testing for anti-tTG
and EMA in children below 2 years of age results in
poor sensitivity,2 and immunosuppression could also
decrease the sensitivity of the tests.
Blood sampling was carried out at the NHP: two tubes
were obtained from each participant, one for serum and
one for whole blood. We searched for IgA anti-tTG in all
the children included in the study. All the positive chil-
dren were then tested for EMA and HLA DQ2/DQ8.
Total IgA concentration was measured in samples with
IgA anti-tTG absorbance ranging from 0 to 0.140, as pre-
viously reported,16 and serum samples with IgA deﬁ-
ciency (IgA serum concentration <7 mg/dL) were tested
for IgG anti-tTG.
Furthermore, a random selection of children who
tested negative for anti-tTG and EMA were also evalu-
ated for CD-related HLA. According to the ESPGHAN
criteria,2 a participant is deﬁned as being at risk for
having CD when positive for anti-tTG and EMA in the
presence of HLA DQ2/DQ8.
A questionnaire was used to collect demographic data
(sex, date of birth, current therapies), information on
signs and symptoms known to be related to CD (recent
symptoms of abdominal discomfort or fatigue), and on
the approximate amount of gluten consumed weekly
(noodles, bread or snacks: never, once a day, more or
less than once a week).
Serological assays and HLA typing
Serum samples were examined in duplicate at the NHP
laboratory for IgA anti-tTG, using an ELISA assay (Eu-tTG,
Eurospital, Trieste, Italy) according to the manufacturer’s
instructions (normal values <9 U/mL). Quantitative deter-
mination of human IgA in serum was carried out in Italy
using an immunoassay (Roche/Hitachi Cobas c system,
Indianapolis, Indiana, USA), following the manufacturer’s
instructions. Serum EMA were evaluated by indirect
immunoﬂuorescence on cryostat sections of human umbil-
ical cord, as previously described.3
The susceptibility alleles for CD were determined by
PCR with allele-speciﬁc primers identifying HLA DQ2
and DQ8, using an Eu-Gene-Risk kit (Eurospital, Trieste,
Italy). The kit serves to identify all DQ2-positive partici-
pants carrying both DQ2.5 (HLA-DQA1*05, DQB1*02
in cis with DR3 or in trans with the DR5/DR7 haplo-
types) and DQ2.2 heterodimers (HLA-DQA1*02,
DQB1*02, DRB1*07), and those positive for DQ8
(HLA-DQA1*03, DQB1*03:02, DRB1*04).
Statistical analysis
Continuous data were presented as mean±SD for nor-
mally distributed parameters, and median and IQR for
skewed variables. Dichotomous variables were presented
as frequency and percentage.
Ethical considerations
Written informed consent was obtained from the chil-
dren’s parents before proceeding with the tests.
RESULTS
Study population
The parents of 2045 children agreed to participate in
the study. Eighty-four children (4%) were excluded due
to inadequate serum samples (63 children) or to
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exclusion criteria (15 with leukaemia, 3 in chemother-
apy, 1 in radiotherapy, 2 under 2 years of age). Nineteen
hundred and sixty-one children (96%) were enrolled in
the study (838 females, 1123 males, median age
5.3 years and IQR 4–7.5 years). Reasons for having blood
drawn included an array of general paediatric diseases:
respiratory tract infections, fever, gastroenteritis, cough,
hepatitis, thalassaemia major, anaemia, abdominal pain,
nephrotic syndrome, glomerulonephritis, stunted
growth, thyroiditis, diabetes, arthritis, asthma, tubercu-
losis, urinary tract infection, dengue, Henoch-Schonlein
purpura and immune thrombocytopenia.
Twenty per cent of the children (387/1961) presented
with gastrointestinal symptoms (266 of recurrent abdom-
inal pain, 87 anorexia, 58 diarrhoea). One hundred and
twenty-eight others were being worked up because of
failure to thrive. Exposure to gluten was reported by
88% of the patients’ parents. Four per cent of them ate
foods containing gluten every day, 40% at least once a
week and 56% less than once a week.
Anti-tTG, EMA and HLA typing
Twenty-one children out of 1961 (8 females, 13 males)
tested positive for IgA anti-tTG (1%; 95% CI 0.61% to
1.53%) and 17 of the 21 had a history of eating gluten.
However, EMA antibodies were negative in all of them.
Seven of the 21 (33%) carried the CD-related HLA
(table 1), but only in 2 (0.1% of the total population)
was the titre of anti-tTG antibodies higher than three
times the upper limit of normal (positive predictive
value 95%).17 One patient had an IgA anti-tTG titre 10
times higher than the upper limit of normal values but
his HLA DQ2/8 was negative. HLA DQ2/8 was present
in 7/21 (33%; 95% CI 14.5% to 56.9%) of the
anti-tTG-positive children. The HLA DQ2/8 was mea-
sured also in 275/1961 (14%) children (selected by
means of a computational random number generator)
who had tested negative for anti-tTG and EMA, and
72/275 (26%; 95% CI 21% to 32%) demonstrated pres-
ence of the HLA DQ2/8.
IgA anti-tTG absorbance ranging from 0 to 0.140 was
present in 162/1961 children (8%) and 5/162 (3%: 3
females, 2 males, median age 6.4 years) had total IgA
deﬁciency. These ﬁve children were tested and were
found to be negative for IgG anti-tTG. The results of the
study are shown in ﬁgure 1.
DISCUSSION
This is the ﬁrst study on the prevalence of coeliac-
speciﬁc antibodies among Vietnamese children.
CD is considered to be rare in the Asia-Paciﬁc region.
Therefore, we screened a large sample of children who
had not previously been diagnosed with CD, by means
of sensitive and speciﬁc sequential serological tests.
Overall, 21 children were found to be anti-tTG IgA posi-
tive, but the EMA test was negative in all, and only 7/21
were positive for CD-related HLA. Only two children
were potentially affected by CD, having high levels of
anti-tTG and being DQ2/DQ8 positive. However, both
Table 1 Demographic, serology, HLA, and gluten exposure in Vietnamese children positive for IgA anti-tTG
Patient Sex
Age
(years)
IgA anti-tTG
(U/mL)
IgA anti-tTG
absorbance HLA
EMA
(+/−)
Gluten
exposure
Gluten consumption
frequency
V731 M 4 9 0.628 N – Yes >1 per week
V348 F 10 9 0.648 N – Yes <1 per week
V1755 M 11 10 0.659 N – Yes >1 per week
V1057 M 8 10 0.632 DQ8 – No
V703 M 6 10.5 0.659 N – Yes >1 per week
V525 F 17 12 0.712 N – No
V715 F 6 13.5 0.731 N – Yes <1 per week
V800 M 6 14 0.779 DQ2.5 – Yes <1 per week
V949 M 4 14 0.733 DQ2.5/8 – Yes <1 per week
V431 F 4 16 0.794 DQ2.5 – Yes >1 per week
V736 M 3 16 0.803 N – No
V1417 F 9 17 0.846 N – Yes <1 per week
V1872 F 5 18.5 0.832 N – Yes <1 per week
V1521 M 6 21.5 1.021 DQ2.5 – Yes >1 per week
V517 M 9 37 1.3 N – Yes <1 per week
V510 F 9 40 1.303 N – Yes <1 per week
V170 M 8 45 1.341 DQ2.5 – Yes >1 per week
V1965 M 7 54 1.692 N – Yes >1 per week
V1037 F 8 64 1.852 N – Yes >1 per week
V148 M 9 74 2.195 DQ2.2 – Yes <1 per week
V963* M 10 105 3.045 N – No
*IgA anti-tTG titre was 10 times higher than the upper limit of normal values but HLA DQ2/8 was negative.
Anti-tTG, antitransglutaminase antibodies; EMA, antiendomysial antibodies; F, female; HLA N, HLA DQ2/8 negative; M, male.
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were EMA negative. According to the literature and the
recent ESPGHAN2 and BSPGHAN18 guidelines for CD
diagnosis, the EMA test is considered a gold standard
immunological biomarker as sensitive as, but more spe-
ciﬁc than, anti-tTG, the increase of which might be
caused also by parasitosis.19 The remainder of the chil-
dren who tested positive for DQ2 and DQ8 were
anti-tTG and EMA negative.
All the screening studies performed so far in the
Eastern Hemisphere have identiﬁed the presence of CD
autoimmunity in variable percentages. In India, CD has
been well recognised, especially in the north, and two
population-based studies revealed a prevalence of 0.3 to
1.04%.20 According to a meta-analysis,21 the number of
reported cases of CD is extremely low in China,
although a study of children with chronic diarrhoea
showed a histologically proven frequency of CD equal-
ling 12%.22 Preliminary data from Japan and Singapore
suggest the existence of CD also in these countries.6 A
study from Malaysia reported a prevalence of 1.9% in
adult females and 0.4% in males as demonstrated by
positive IgA/IgG antigliadin antibodies, IgA/IgG
anti-tTG and EMA.7
The pathogenesis of CD is linked to involvement of
the HLA molecules, DQ2 or DQ8, which present gluten
antigens to speciﬁc T-cells. Their presence is a condition
not sufﬁcient but necessary condition to develop CD.
The typical HLA alleles were present in 26% of the
Hanoi children examined, a number similar to the per-
centages found in most populations.13 The low preva-
lence of CD autoimmunity in our northern Vietnamese
paediatric population is therefore somewhat surprising,
especially in consideration of the fact that HLA
genotyping suggests that the risk for CD exists also in
Vietnam.
Possible explanations for this ﬁnding could be the
young median age of the children screened (5.3 years)
or the scarce and late introduction of gluten. A recent
multicentre, prospective European study demonstrated
that, although late introduction of gluten did not
decrease the risk of developing CD in children with pre-
disposing conditions, it delayed the onset of the
disease.23 Approximately half of the Vietnamese chil-
dren that we examined ate gluten-containing foods less
than once a week, and 10% did not eat gluten at all.
This fact could be responsible for the rarity of coeliac
autoimmunity.
IgA deﬁciency occurs more frequently in patients with
CD (1.30%) than in the general population (0.13 to
0.25%), a fact that might cause false-negative results.24
In our study, the children who were considered as being
possibly affected by total or partial IgA deﬁciency16 on
the basis of low IgA anti-tTG absorbance were tested
with IgG anti-tTG and found to be negative.
In our population, there was a prevalence of males.
This difference reﬂects the male-to-female ratio, which
averages 120:100 (45% female) in the Red River Delta
(Hanoi City) and 110:100 (47% female) in the rest of
the northern areas.25
Our results are similar to those recently reported
from Colombia, where healthy individuals and those
affected by autoimmune disorders were both tested
with anti-tTG and EMA. Among patients with auto-
immune disorders, seven individuals tested positive or
weakly positive for anti-tTG, but IgA EMA were nega-
tive in all cases.26
Figure 1 Flow chart showing results of the study. Anti-tTG, antitransglutaminase antibodies; EMA, antiendomysial antibodies.
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Strengths and limitations of the study
The strength of our study lies in the fact that this is the
ﬁrst research on CD autoimmunity in Vietnam; in the
large number of children examined by ELISA for
anti-tTG; in the further testing by EMA of positive sera,
and in the HLA typing for DQ2 and DQ8 of the
anti-tTG-positive children. Also, in children affected by
total or partial IgA deﬁciency, anti-tTG IgG were mea-
sured. The amount of gluten introduced with food was
estimated by means of a detailed questionnaire with the
best possible accuracy.
The study was performed on children having blood
drawn as outpatients at a hospital laboratory, who there-
fore were not completely healthy. However, if anything,
this potential selection bias should have increased the
prevalence of CD in our sample. The median age of
children was 5 years, and we do not know if CD auto-
immunity will develop with passing years. A
small-intestinal biopsy could not possibly be performed
and therefore the presence of histological lesions in the
two patients (V170, V148) with high anti-tTG antibody
concentration carrying the CD-related HLA cannot be
completely excluded. Both had been exposed to dietary
gluten.
Future developments
New studies on the Southeast Asian population might
clarify whether the prevalence of CD increases with age
and if there is a strict correlation with the amount of
gluten introduced with the diet. It will be of interest to
follow children on a completely gluten-free diet and
compare them with children from the same area whose
diet includes gluten-containing foods.
CONCLUSIONS
None of the 1961 Vietnamese children examined were
positive for coeliac autoimmunity on the basis of positiv-
ity for anti-tTG and EMA. The extremely low prevalence
of CD in this large population of children could be due
to low exposure to gluten coupled with the young age of
the children.
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